Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 179-184

  Hu, Jiabo ^a   Zhou, Zhongwei ^a,c   Shi, Shunbin ^b   Zhu, Xiaozhong ^b   Wang, Xiaohui ^a   Zhang, Wei ^a   Hu, Sanqiang ^a   Qian, Hui ^a   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^c Yancheng Third People's Hospital   (China)

Author keywords

Cell isolation; Esophageal carcinoma; Mesenchymal stem like cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; BETA1 INTEGRIN; BMI1 PROTEIN; CYTOKERATIN 18; ENDOGLIN; HERMES ANTIGEN; MICROSOMAL AMINOPEPTIDASE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL SHAPE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; TUMOR MICROENVIRONMENT;

EID: 84869059649     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1003     Document Type: Article

References (37)

1. Horwitz EM, Le Blanc K, Dominici M, et al: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395, 2005.
2. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S and Yasunaga Y: Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng 10: 1093-1112, 2004.
3. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152, 2005.
4. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549, 2003.
5. Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP and Caplan AI: In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 195: 492-503, 1991,
6. Zuk PA, Zhu M, Ashjian P, et al: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295, 2002.
7. Kim SM, Lim JY, Park SI, et al: Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 68: 9614-9623, 2008.
8. Bieback K and Kluter H: Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2: 310-323, 2007.
9. Flynn A, Barry F, and O'Brien T: UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 9: 717-726, 2007.
10. Gucciardo L, Lories R, Ochsenbein-Kölble N, Done' E, Zwijsen A and Deprest J: Fetal mesenchymal stem cells: Isolation, properties and potential use in perinatology and regenerative medicine. BJOG 116: 166-172, 2009.
11. Lin TM, Chang HW, Wang KH, et al: Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun 361: 883-889, 2007.
12. Gibbs CP, Kukekov VG, Reith JD, et al: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7: 967-976, 2005.
13. Xu X, Zhang X, Wang S, et al: Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. Cancer Res Clin Oncol 137: 495-504, 2011.
14. Sun X, Cai H, Qian H, Zhu W, Yan Y, Xu H and Xu W: Mesenchymal stem cells isolated from human uterine cervix cancer tissues. Cell Biol Int 35: 119-123, 2011.
15. Khakoo AY, Pati S, Anderson SA, et al: Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203: 1235-1247, 2006.
16. Xu WT, Bian ZY, Fan QM, Li G and Tang TT: Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 281: 32-41, 2009.
17. Ahmed N, Abubaker K, Findlay J and Quinn M: Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10: 268-278, 2010.
18. Moon JH, Kwak SS, Park G, et al: Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells. Stem Cells Dev 17: 713-724, 2008.
19. Bruno S, Bussolati B, Grange C, et al: Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev 18: 867-879, 2009.
20. Mitrano TI, Grob MS, Carrión F, et al: Culture and characterization of mesenchymal stem cells from human gingival tissue. J Periodontol 81: 917-925, 2010.
21. Schüring AN, Schulte N, Kelsch R, Röpke A, Kiesel L and Götte M: Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics. Fertil Steril 95: 423-426, 2011.
22. Zhou ZW, Hu JB, Shi SB, Zhu XZ, Wang XH and Xu WR: Isolation of mesenchymal stem-like cells from human esophageal carcinoma and identification of their biological characteristics. Basic Clin Med 32: 798-803, 2012.
23. Xu W, Zhang X, Qian H, et al: Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 229: 623-631, 2004.
24. Spaeth EL, Dembinski JL, Sasser AK, et al: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992, 2009.
25. Mishra P J, Mishra P J, Humeniuk R, et al: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339, 2008.
26. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K and Salven P: Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104: 2084-2086, 2004.
27. Bergfeld SA and DeClerck YA: Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 29: 249-261, 2010.
28. Hall B, Andreeff M and Marini F: The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 180: 263-283, 2007.
29. Kidd S, Spaeth E, Dembinski JL, et al: Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27: 2614-2623, 2009.
30. Attasi Y, Mowla SJ, Ziaee SA, et al: Oct-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120: 1598-1602, 2007.
31. Chiou SH, Yu CC, Huang CY, et al: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095, 2008.
32. Wang H, Pan K, Zhang HK, et al: Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 134: 535-541, 2008.
33. Kim JH, Yoon SY, Kim CN, et al: The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 203: 217-224, 2004.
34. Maeda K, Chung YS, Ogawa Y, et al: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863, 1996.
35. Takanami I, Tanaka F, Hashizume T and Kodaira S: Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 17: 2811-2814, 1997.
36. Xu W, Zhang MW, Huang J, Wang X, Xu SF, Li Y and Wang SJ: Correlation between CK18 gene and gastric carcinoma micrometastasis. World J Gastroenterol 11: 6530-6534, 2005.
37. Nanda KD, Ranganathan K, Devi U and Joshua E: Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: An immunohistochemistry study. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 245-253, 2012.